We are live on ! Find out more
CA

Corriente Advisors Portfolio holdings

AUM $9.53M
1-Year Est. Return 805.26%
This Fund
S&P 500
This Quarter Est. Return
+7.12%
1 Year Est. Return
+805.26%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$11.7M
AUM Growth
-$40.1M
Cap. Flow
-$38.7M
Cap. Flow %
-331.16%
Top 10 Hldgs %
100%
Holding
11
New
3
Increased
Reduced
Closed
8

Sector Composition

Rank Sector Weight
1 Energy 45.66%
2 Consumer Discretionary 25.57%
3 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRN
1
DELISTED
Veren
VRN
$5.34M 45.66%
+1,000,000
New +$4.87M
APRN
2
CALL
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$3.37M 28.77%
+41,667
New +$4.34M
APRN
3
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$2.99M 25.57%
+37,039
New +$3.86M
CCJ icon
4
Cameco
CCJ
$37.3B
-20,000
Closed -$435K
CUE icon
5
Cue Biopharma
CUE
$131M
-31,613
Closed -$13.8M
CVE icon
6
Cenovus Energy
CVE
$52.1B
-540,000
Closed -$5.44M
LTRN icon
7
Lantern Pharma
LTRN
$36.6M
-625,873
Closed -$7M
VET icon
8
Vermilion Energy
VET
$1.51B
-700,000
Closed -$6.91M
TFFP
9
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
-40,794
Closed -$7.87M
SWN
10
DELISTED
Southwestern Energy Company
SWN
-1,550,000
Closed -$8.59M

Similar funds

Corriente Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Corriente Advisors held 11 positions worth $11.7M, down 77% from $51.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Corriente Advisors withdrew a net $38.7M in Q4 2021, closing 8 positions. Its most notable exit was Cue Biopharma, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Energy at 46% of assets, up from 41% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Corriente Advisors opened a new position in Veren worth $5.34M.

  • Corriente Advisors's largest Q4 2021 buy was Veren: 1,000,000 shares worth $5.34M.
  • Corriente Advisors fully exited Cue Biopharma in Q4 2021, selling an estimated $13.8M.
  • Corriente Advisors's ten largest holdings make up 100% of its $11.7M portfolio in Q4 2021.
  • Corriente Advisors opened 3 new positions and closed 8 in Q4 2021.
  • Corriente Advisors's portfolio value fell 77% quarter-over-quarter to $11.7M.

Based on Corriente Advisors's 13F filing for Q4 2021, filed 15 Feb 2022.